Figure 3

AAV-STARR-seq validation procedure. (A) Schematic illustrating AAV-STARR-seq validation procedure. (B) Scatterplot of AAV-STARR-seq screen signal (RNA/input DNA log2 fold change, averaged across mice) and fluorescence microscopy-based validation signal (log10 median relative fluorescence strength compared to CMV promoter; see Fig. 4) for 9 validation candidates with varying predicted enhancer activity.